Tabhu: tools for antibody humanization

por Olimpieri, Pier Paolo, Marcatili, Paolo, Tramontano, Anna
Publicado 2015

Prediction of site-specific interactions in antibody-antigen complexes: the proABC method and server

por Olimpieri, Pier Paolo, Chailyan, Anna, Tramontano, Anna, Marcatili, Paolo
Publicado 2013

Superposition-free comparison and clustering of antibody binding sites: implications for the prediction of the nature of their antigen

por Di Rienzo, Lorenzo, Milanetti, Edoardo, Lepore, Rosalba, Olimpieri, Pier Paolo, Tramontano, Anna
Publicado 2017

Shape Complementarity Optimization of Antibody–Antigen Interfaces: The Application to SARS-CoV-2 Spike Protein

por De Lauro, Alfredo, Di Rienzo, Lorenzo, Miotto, Mattia, Olimpieri, Pier Paolo, Milanetti, Edoardo, Ruocco, Giancarlo
Publicado 2022

Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy

por Russo, Pierluigi, Tacconelli, Evelina, Olimpieri, Pier Paolo, Celant, Simone, Colatrella, Antonietta, Tomassini, Luca, Palù, Giorgio
Publicado 2022

Chemosensory adaptations of the mountain fly Drosophila nigrosparsa (Insecta: Diptera) through genomics’ and structural biology’s lenses

por Cicconardi, Francesco, Di Marino, Daniele, Olimpieri, Pier Paolo, Arthofer, Wolfgang, Schlick-Steiner, Birgit C., Steiner, Florian M.
Publicado 2017

Insights on protein thermal stability: a graph representation of molecular interactions

por Miotto, Mattia, Olimpieri, Pier Paolo, Di Rienzo, Lorenzo, Ambrosetti, Francesco, Corsi, Pietro, Lepore, Rosalba, Tartaglia, Gian Gaetano, Milanetti, Edoardo
Publicado 2019

proABC-2: PRediction of AntiBody contacts v2 and its application to information-driven docking

por Ambrosetti, Francesco, Olsen, Tobias Hegelund, Olimpieri, Pier Paolo, Jiménez-García, Brian, Milanetti, Edoardo, Marcatilli, Paolo, Bonvin, Alexandre M J J
Publicado 2020

How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis f...

por Breccia, Massimo, Olimpieri, Pier Paolo, Olimpieri, Odoardo, Pane, Fabrizio, Iurlo, Alessandra, Foggi, Paolo, Cirilli, Alessia, Colatrella, Antonietta, Cuomo, Marcello, Gozzo, Lucia, Summa, Valentina, Corradini, Paolo, Russo, Pierluigi
Publicado 2020

Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency

por Rigolin, Gian Matteo, Olimpieri, Pier Paolo, Summa, Valentina, Celant, Simone, Scarfò, Lydia, Tognolo, Lucia, Ballardini, Maria Pia, Urso, Antonio, Sessa, Mariarosaria, Gambara, Silvia, Cura, Francesca, Fortini, Monica, Ghia, Paolo, Cuneo, Antonio, Russo, Pierluigi
Publicado 2023

Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron...

por Torti, Carlo, Olimpieri, Pier Paolo, Bonfanti, Paolo, Tascini, Carlo, Celant, Simone, Tacconi, Danilo, Nicastri, Emanuele, Tacconelli, Evelina, Cacopardo, Bruno, Perrella, Alessandro, Buccoliero, Giovanni Battista, Parruti, Giustino, Bassetti, Matteo, Biagetti, Carlo, Giacometti, Andrea, Erne, Elke Maria, Frontuto, Maria, Lanzafame, Massimiliano, Summa, Valentina, Spagnoli, Alessandra, Vestri, Annarita, Di Perri, Giovanni, Russo, Pierluigi, Palù, Giorgio
Publicado 2023